A Saga of Vaccine Development: Past, Present, and Future
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 321
Special Issue Editors
Interests: Alzheimer’s disease; Parkinson’s disease; gangliosides; bioactive; natural compounds; drug discovery
Interests: neurodegenerative disorders; Parkinson’s disease; autophagy; diagnostics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vaccines have been around since Louis Pasteur discovered the first lab vaccine in 1879. Since then, vaccinations have come a long way, and with the advancement of vaccinations, several viral diseases have been eradicated or nearly eliminated, thereby proving the protective powers of vaccinations. The success stories include smallpox, rabies, anthrax, yellow fever, measles, adenoviruses, varicella, etc. Vaccines for other infectious diseases, however, are still a long way off, such as malaria and HIV. Nevertheless, a sudden and rapid advancement has been seen in the field of vaccine technology due to the ongoing global coronavirus pandemic, which may very well usher in a new era in vaccine development.
The Special Issue “A Saga of Vaccine Development: Past, Present, And Future” aims to provide a forum for review articles that highlights vaccines in all their glory. In this Special Issue, we focus on vaccines in different times and places—the known past with its success and failures stories, the uncertain present with ongoing global pandemics, and the unknown but optimistic future that lies ahead.
The topic of interest include, but are not limited to, review articles that describe interventions in vaccines:
- Exploratory phase in vaccine development;
- Preclinical phase in vaccine development;
- Clinical studies in vaccine development;
- Genetic engineering in vaccine development;
- Live attenuated virus vaccine;
- Inactivated vaccines;
- Subunit vaccines;
- Nucleic acid vaccines;
- New target for vaccination;
- Immunization;
- Vaccine platforms and delivery systems;
- Vaccines in the age current global pandemic, COVID 19.
We look forward to receiving your contributions.
Dr. Suman Chowdhury
Dr. Ranjeet Kumar
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccination
- vaccine development
- immunization
- vaccine delivery
- COVID-19 vaccine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
